Breast Cancer

  • Avastin 2015 report

    Avastin 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 26 Pages The 5 Key Questions Addressed by this...

  • Fareston 2015 report

    Fareston 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 27 Pages The 5 Key Questions Addressed by this...

  • Faslodex 2015 report

    Faslodex 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 25 Pages The 5 Key Questions Addressed by this...

  • Halaven 2015 report

    Halaven 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 25 Pages The 5 Key Questions Addressed by this...

  • Herceptin 2015 report

    Herceptin 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 27 Pages The 5 Key Questions Addressed by this...

  • Ibrance 2015 report

    Ibrance 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 22 Pages The 5 Key Questions Addressed by this...

  • Kadcyla 2015 report

    Kadcyla 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 25 Pages The 5 Key Questions Addressed by this...

  • Perjeta 2015 report

    Perjeta 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 25 Pages The 5 Key Questions Addressed by this...

  • Abraxane 2014 report

    Abraxane 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 27 Pages The 5 Key Questions Addressed by this...

  • Afinitor 2014 report

    Afinitor 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 31 Pages The 5 Key Questions Addressed by this...

  • Avastin 2014 report

    Avastin 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 26 Pages The 5 Key Questions Addressed by this...

  • Fareston 2014 report

    Fareston 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 27 Pages The 5 Key Questions Addressed by this...